BF Biosciences Ratios and Metrics

Market cap in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Sep '25 Sep 18, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2019
Debt / Equity Ratio	0.41	0.94	1.32	0.96	0.61	0.01	Upgrade
Debt / EBITDA Ratio	2.06	2.96	8.57	6.45	1.42	0.18	Upgrade
Debt / FCF Ratio	-	4.27	-	-	-	-	Upgrade
Asset Turnover	0.71	0.64	0.36	0.41	0.87	0.65	Upgrade
Inventory Turnover	2.19	2.44	2.16	2.79	3.24	2.66	Upgrade
Quick Ratio	1.11	0.40	0.39	2.47	3.16	2.23	Upgrade
Current Ratio	2.42	1.17	1.13	3.21	4.19	3.51	Upgrade
Return on Equity (ROE)	11.48%	17.79%	7.85%	18.65%	54.07%	6.21%	Upgrade
Return on Assets (ROA)	6.74%	7.71%	3.33%	4.08%	18.59%	0.96%	Upgrade
Return on Capital (ROIC)	8.71%	9.72%	4.13%	5.11%	23.89%	1.20%	Upgrade
Return on Capital Employed (ROCE)	11.60%	16.00%	6.30%	6.50%	23.80%	1.90%	Upgrade
Buyback Yield / Dilution	-17.77%	-	-0.01%	-	-	-	Upgrade

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.